Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population

Oncotarget

Volumn 6, Issue 35, 2015, Pages 36955-36964

  Xiao, Qianyi ^a   Liu, Zhi Jun ^b,c   Tao, Sha ^a   Sun, Yi Min ^c   Jiang, Deke ^a   Li, Hong Lei ^b   Chen, Haitao ^a   Liu, Xu ^a   Lapin, Brittany ^d   Wang, Chi Hsiung ^d   Lilly Zheng, S ^a,d   Xu, Jianfeng ^a,c,d   Wu, Zhi Ying ^b  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Alzheimer's disease; Association; Genetic risk score; Gerotarget; Risk prediction; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER;

AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; FERMT2 GENE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; GENOTYPING TECHNIQUE; HAN CHINESE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PVRL2 GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84947784176     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6271     Document Type: Article

References (46)

1. Wimo A, Jonsson L, Bond J, Prince M and Winblad B. The worldwide economic impact of dementia 2010. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2013; 9:1-11 e13.
2. Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, Wang W and Rudan I. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013; 381:2016-2023.
3. Norton S, Matthews FE, Barnes DE, Yaffe K and Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology. 2014; 13:788-794.
4. Small SA and Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron. 2008; 60:534-542.
5. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L and et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349:704-706.
6. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K and et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science (New York, NY). 1995; 269:973-977.
7. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T and et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995; 376:775-778.
8. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995; 375:754-760.
9. Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V and et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Human molecular genetics. 1994; 3:569-574.
10. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL and Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (New York, NY). 1993; 261:921-923.
11. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S and Aasly JO. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC neurology. 2008; 8:9.
12. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A and Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature genetics. 1994; 7:74-78.
13. Ashford JW and Mortimer JA. Non-familial Alzheimer's disease is mainly due to genetic factors. Journal of Alzheimer's disease: JAD. 2002; 4:169-177.
14. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature genetics. 2009; 41:1088-1093.
15. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature genetics. 2011; 43:429-435.
16. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature genetics. 2009; 41:1094-1099.
17. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature genetics. 2011; 43:436-441.
18. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. Jama. 2010; 303:1832-1840.
19. Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, Konidari I, Whitehead PL, Cai G, Haroutunian V, Scott WK, Vance JM, Slifer MA, Gwirtsman HE, et al. Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS genetics. 2010; 6:e1001130.
20. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics. 2013; 45:1452-1458.
21. Chen LH, Kao PY, Fan YH, Ho DT, Chan CS, Yik PY, Ha JC, Chu LW and Song YQ. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population. Neurobiology of aging. 2012; 33:210 e211-217.
22. Deng YL, Liu LH, Wang Y, Tang HD, Ren RJ, Xu W, Ma JF, Wang LL, Zhuang JP, Wang G and Chen SD. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease. Human genetics. 2012; 131:1245-1249.
23. Liu LH, Xu J, Deng YL, Tang HD, Wang Y, Ren RJ, Xu W, Ma JF, Wang G and Chen SD. A complex association of ABCA7 genotypes with sporadic Alzheimer disease in Chinese Han population. Alzheimer disease and associated disorders. 2014; 28:141-144.
24. Ma JF, Liu LH, Zhang Y, Wang Y, Deng YL, Huang Y, Wang G, Xu W, Cui PJ, Fei QZ, Ding JQ, Tang HD and Chen SD. Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population. American journal of Alzheimer's disease and other dementias. 2011; 26:627-630.
25. Tan L, Yu JT, Zhang W, Wu ZC, Zhang Q, Liu QY, Wang W, Wang HF, Ma XY and Cui WZ. Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2013; 9:546-553.
26. Ma XY, Yu JT, Wu ZC, Zhang Q, Liu QY, Wang HF, Wang W and Tan L. Replication of the MTHFD1L gene association with late-onset Alzheimer's disease in a Northern Han Chinese population. Journal of Alzheimer's disease: JAD. 2012; 29:521-525.
27. Ma XY, Yu JT, Wang W, Wang HF, Liu QY, Zhang W and Tan L. Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population. Neuromolecular medicine. 2013; 15:279-287.
28. Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB, Jr., Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, et al. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial. European urology. 2012; 62:953-961.
29. Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, et al. Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute. 2015; 107.
30. Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang SJ and O'Donnell CJ. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circulation Cardiovascular genetics. 2012; 5:113-121.
31. Tam CH, Ho JS, Wang Y, Lam VK, Lee HM, Jiang G, Lau ES, Kong AP, Fan X, Woo JL, Tsui SK, Ng MC, So WY, et al. Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes. PloS one. 2013; 8:e83093.
32. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N and van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama. 1997; 278:1349-1356.
33. van Duijn CM, Clayton D, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. International journal of epidemiology. 1991; 20 Suppl 2:S13-20.
34. Fratiglioni L, Ahlbom A, Viitanen M and Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Annals of neurology. 1993; 33:258-266.
35. Payami H, Grimslid H, Oken B, Camicioli R, Sexton G, Dame A, Howieson D and Kaye J. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. American journal of human genetics. 1997; 60:948-956.
36. Wolf G and Stahl RA. CD2-associated protein and glomerular disease. Lancet. 2003; 362:1746-1748.
37. Lai-Cheong JE, Parsons M and McGrath JA. The role of kindlins in cell biology and relevance to human disease. The international journal of biochemistry & cell biology. 2010; 42:595-603.
38. Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, Chipendo P, Chibnik LB, Diamond A, Perrimon N, Brown NH, De Jager PL and Feany MB. Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms. Human molecular genetics. 2014; 23:870-877.
39. Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, Legallic S, Paquet C, Bombois S, Pariente J, Thomas-Anterion C, Michon A, Croisile B, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Molecular psychiatry. 2012; 17:875-879.
40. Alexopoulos P, Guo LH, Kratzer M, Westerteicher C, Kurz A and Perneczky R. Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers. Dementia and geriatric cognitive disorders. 2011; 32:164-170.
41. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of internal medicine. 2004; 256:240-246.
42. Mittal VA and Walker EF. Diagnostic and statistical manual of mental disorders. Psychiatry research. 2011; 189:158-159.
43. Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K and Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clinical chemistry. 1999; 45:143-146.
44. Pharoah PD, Antoniou AC, Easton DF and Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. The New England journal of medicine. 2008; 358:2796-2803.
45. DeLong ER, DeLong DM and Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44:837-845.
46. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ and Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics. 2007; 81:559-575.